Upload
zwi
View
37
Download
3
Tags:
Embed Size (px)
DESCRIPTION
Evaluation of European Pharmacopoeia Method for Analysis of Hydroxypropylbetadex: Proposal for Improvement. Katalin Csabai, 1 Julianna Szemán 1 , Gábor Varga 2, Lajos Szente 1. 1 CycloLab Cyclodextrin R&D Laboratory Ltd., Budapest, Hungary, e-mail : szeman .j @cyclolab.hu - PowerPoint PPT Presentation
Citation preview
Evaluation of European Pharmacopoeia Method for Analysis of Evaluation of European Pharmacopoeia Method for Analysis of
Hydroxypropylbetadex: Proposal for ImprovementHydroxypropylbetadex: Proposal for Improvement
1 CycloLab Cyclodextrin R&D Laboratory Ltd., Budapest, Hungary, e-mail: [email protected] 2 ChiroQuest Chiral Technologies Development Ltd., Budapest, Hungary
Katalin Csabai,1 Julianna Szemán1, Gábor Varga2, Lajos Szente1
Hydroxypropylbetadex ((2-hydroxy)propyl -cyclodextrin, HPBCD) a statistically substituted derivative of Betadex (-cyclodextrin, BCD), has long been used successfully as additive in drug delivery to increase the aqueous solubility and stability of drugs - even in marketed drug products. For identification and characterisation of the statistically substituted cyclodextrin derivatives – like HPBCD – fingerprint chromatograms obtained on reversed phase (C8, C18, Phenyl) or normal phase (amino bonded silica) HPLC column are used [1-10].
European Pharmacopoeia (EP) prescribes phenylsilyl silica gel stationary phase with water as mobile phase for determination of the remnant un-substituted BCD and propylene glycol (PRG) in HPBCD. The separation is based on inclusion complex formation between of the phenyl groups on the stationary phases and the analyte cyclodextrins. The different separation potency of phenyl columns (surface coverage, free silanols) obtained from different manufacturers, however, has a strong influence on the separation of cyclodextrin derivatives [10].
In this work we have studied applicability of the Pharmacopoeia method considering the knowledge of the inclusion complex formation properties of the substituted cyclodextrin derivatives. An alternative analysis method is also given using a special phenyl column developed for cyclodextrin analysis [11].
INTRODUCTIONINTRODUCTION
Description: European Pharmacopoeia 5.04 (Page 1771-73)
Related substances. Liquid chromatography
Column: - size: l = 0.30 m, Ø=3.9 mm - stationary phase: phenylsilyl silica gel for chromatography R,
- temperature: 40CMobile phase: water for chromatography R
Flow rate: 1.5 ml/min
Detection: differential refractometer, at 40CRun time: 3 times the retention time of BCD
Relative retention (r): with reference to impurity B (PRG) (tR = about 2.5 min.); impurity A (BCD) about 4.2;Hydroxypropylbetadex about 6 for the beginning o f the elution
System suitability: - resolution: minimum 4 between the peaks due to impurity BCD and impurity PRG
Hydroxypropylbetadex elutes as a very wide peak or several peaks
RESULTS RESULTS ANDAND DISCUSSION DISCUSSION
Theoretical considerations The components of HPBCD form strong inclusion complexes with phenyl groups depending on the degree of substitution of the respective components. In all probability, some components of HPBCD can not be eluted from the column by water.
• Propylene glycol (PRG) has very low retention on phenyl columns (retention factor 0.1-1.1), therefore its evaluation is disturbed by the system peaks caused by the water content of samples
• The resolution between BCD and PRG is better than the prescribed limit (Rs minimum 4), except AlphaBond column
• Although the tested columns meets the requirement of the EP method, the relative retention of BCD is lower than the given value
• The relative retention of the first peak of HPBCD is lower than the given value (r ~ 6)
• The resolution between the BCD peak and the first HPBCD peak is very low on the AlphaBond column
• The baseline is not stable at the prescribed run time (3 times the retention time of BCD), components of HPBCD remained on the column???
Adaptation of EP method on different phenyl columns
Characteristic data on three different phenyl columns
AlphaBond Phenyl
Chromatograms of BCD, PRG and HPBCD Mobile phase: water, RI detection
l : 0.25m, Ø:4.6mm, particle size: 5m
YMC-Pack PhenylBondapack Phenyll : 0.3m, Ø:4.6mm, particle size:10m l : 0.30m, Ø:3.9mm, particle size: 10m
min5 10 15 20 25
mV
0
20
40
60
80
100
ADC1 A, ADC1 CHANNEL A (S:\HPLC1\CDDERI~1\HPBE0311\HPBCD11.D)
BC
D
Pump 1, Solvent B: VIZ:MEOH=10:90 (11-Mar-05, 11:28:33)
min5 10 15 20 25
mV
0
20
40
60
80
100
120
140
ADC1 A, ADC1 CHANNEL A (E:\CDPHDATA\YMC0921\HPBCD1.D)
BC
D
Pump 1, Solvent B: MeOH-DV 9-1 v/v (21-Sep-04, 12:58:47)
Chromatograms of BCD, PRG and HPBCD Mobile phase: water, gradient with methanol, ELS detection
High amount of HPBCD was washed by the methanol gradient from the columns
Effect of the non-eluted HPBCD on the separation
Consecutive injection of HPBCD (Bondapack column, run time: 3 times of BCD retention time)
Washing procedure using RI detection
• The baseline is not stable, and shifted to higher refraction values, therefore the evaluation of peak areas is doubtful
• The retention time of BCD peak shows decreasing tendency
Change of reference chromatograms Change of HPBCD chromatograms
min10 20 30 40 50 60 70 80 90
RIU
40
60
80
100
120
140
160
ADC1 A, ADC1 (G:\DATA\HPBE0823\HPBCDWU1.D)
1. injection
2. injection after washing
ADC1 A, ADC1 (G:\DATA\HPBE0823\HPBCDWU2.D)
CONCLUSIONSCONCLUSIONS
Pharmacopoeia method
Components of HPBCD remained on the column resulted in changed column performance after consecutive injections instable chromatographic system
Washing HPBCD with methanol long analysis time
Resolution between BCD and the first peak of HPBCD is not prescribed, but can influence the evaluation of BCD peak
System peaks disturb the evaluation of propylene glycol (PRG) peak
[1] G. Liu, D. M. Goodall, J.S. Loran; Chirality, 5, 220-223 (1993) [2] N. Rabearimonjy, S. Ounnar, M. Righezza, M. Dreux; Proc. 9th Int. Symp. Cyclodextrins, 1999, p.
19-22, Ed. J.J.T. Labandeira, J.L. Vila-Jato; Kluwer Academic Publishers, Dordrecht. Netherlands[3] K. Koizumi, Y. Kubota, T. Utamura, S. Horiyama; J. Chromatogr., 368, 329-337 (1986)[4] Y. Kubota, T. Tanimoto, S. Horiyama, K. Koizumi; Carbohydr. Res., 192, 159-166 (1989)[5] G. Schomburg, A. Deege, H. Hinrichs, E. Hübinger; J. High Resolut. Chromatogr., 15, 579-584 (1992)[6] I. Caron, C. Elfakir, M. Dreux; J. Higy Resolut. Chromatogr. 21, 554-560, (1998)[7] I. Caron, A. Salvador, C. Elafkir, B. Herbretau, M. Dreux; J. Chromatogr. A, 746, 103-108 (1996)[8] I. Caron, C. Elafkir, M. Dreux; J. Liq. Chrom. & Rel. Technol., 20, 1015-1035 (1997)[9] A. Salvador, B. Herbretau, M. Dreux; J. Chromatogr. A, 855, 645-656 (1999)[10] I. Caron, C. Elafkir, M. Dreux; Chromatographia 47, 383-390 (1998)[11] J. Szemán, K. Csabai, K. Kékesi, l. Szente, G. Varga; J. Chromatography A, 1116, 76-82 (2006)
REFERENCES
Alternative methodAlternative method
Description:. Liquid chromatographyColumn: - size: l = 0.25m, Ø=4.0 mm
- stationary phase: CD-Screen, a special phenyl type column, developed and tested for separation of cyclodextrins
- temperature: 30C.Mobile phase: methanol and water 45 : 55Flow rate: 0.7 ml/min.Detection: differential refractometer, at 40CRun time: 6 times the retention time of BCD (depends on the degree of substitution
of HPBCD) Relative retention: with reference to impurity B (PRG) (tR = about 4.3 min.);
BCD about 4.8; HPBCD about 6.2 for the beginning of the elutionSystem suitability:- resolution: minimum 2 between peaks due to BCD and the
first peak of HPBCD
min0 10 20 30 40
RIU
60
80
100
120
140
160
180
BC
DH
PB
CD
1.
peak
PR
G
Alternative method
All components of HPBCD are eluted from the column stable chromatographic system, reproducible chromatograms, acceptable run time
HPBCD elutes as a characteristic fingerprint (possibility of identification)
Evaluation of BCD peak is reproducible, resolution between BCD and the first peak of HPBCD is a system suitability factor
System peaks still disturb the evaluation of propylene glycol (PRG) peak use of GC method is advisable
Reproducible chromatograms Six replicate injections of HPBCD
Characteristic fingerprint chromatograms HPBCD samples with different degrees of substitution
Apparatus: Agilent 1050 HPLC system with Evaporative Light Scattering Detector PL-ELS 1000, (Polymer Laboratories), or Refractive Index Detector ERC-7515B (Erkatech) ELS Detector parameters: Evaporation: 110°C, Nebulization: 90 °C, Gas flow: 1.2 l/min. RI Detector parameters: Fast mode, 40°CColumns: AlphaBond Phenyl (Alltech Chromatography, USA), Bondapack Phenyl (Waters Corp., USA), YMC-Pack Phenyl (YMC Europe GmbH), CD-Screen (ChiroQuest Ltd, Hungary) Samples: BCD and HPBCD were products of Cyclolab Ltd., Hungary and Wacker Chemie, Germany.
The authors are grateful to Ms. Zs. Zachár and Ms. E. Erdei to their valuable technical assistance. The work was supplied by the National Research Fund (NKFP-1A-041/2004 and NKFP1-012/2005).
EXPERIMENTAL
ACKNOWLEDGEMENT
• Washing with methanol starts from the run time, and takes minimum 15 min.
• Wash-back to water mobile phase: to get stable base line takes about 80 min.
Necessary run + wash time time about 100 min.
Analysis Washing period
min10 20 30 40
RIU
80
90
100
110
120
130
140
ADC1 A, ADC1 (E:\HPB042\HPB1025\HPBVAL1.D)
DS = 3.5
BC
D
min10 20 30 40
RIU
70
80
90
100
110
ADC1 A, ADC1 (E:\HPB042\HPB1025\74B008.D)
DS = 4.3
BC
D
min10 20 30 40
RIU
77.5
80
82.5
85
87.5
90
92.5
ADC1 A, ADC1 (E:\HPB042\HPB1025\74B004.D)
DS = 6.2
BC
D
min5 10 15 20 25 30 35 40
RIU
80
90
100
110
120
130
ADC1 A, ADC1 (S:\HPLC2\2005RE~1\HPB05\HPBE0301\HPBCD2.D)
Ru
n t
ime
BC
DP
RG
min10 20 30 40 50 60
RIU
70
80
90
100
110
120
130
140
150
ADC1 A, ADC1 (E:\HPB042\HPB0920\HPBCD1.D)
PR
G BC
D
Ru
n t
ime
Pharmacopoeia method
min0 5 10 15 20 25
Norm.
0
20
40
60
80
100
ADC1 A, ADC1 (P:\ARCHIV~1\HPBCD-EP\HPB0322\HPBG2R2.D)
BC
D
PMP1, Solvent B
min10 20 30 40
RIU
120
140
160
180
200
220
PR
G
BC
D
Ru
n t
ime
min0 2 4 6 8 10 12 14 16 18
RIU
100
120
140
160
180
200
220
240
PR
G
BC
D
HP
BC
Dfi
rst p
eak
No. of injection
6
4
2
1
min0 2 4 6 8 10 12 14 16 18
RIU
100
150
200
250
300
350
PR
G
BC
D
No. of injection
6
4
2
1
BC
D
13.1
9.81
2.46
Resolution BCD / PRG
Prescribed: minimum 4
8.94.82.63.11YMC-Pack
4.23.72.42.62Bondapack
1.33.82.72.25AlphaBond
Resolution BCD / HPBCDNot prescribed
Relative ret. of HPBCD
Prescribed: ~ 6
Relative ret. of BCD
Prescribed: ~ 4
Retention time of PRG
Prescribed: ~2.5 min
Phenyl stationary
phase
13.1
9.81
2.46
Resolution BCD / PRG
Prescribed: minimum 4
8.94.82.63.11YMC-Pack
4.23.72.42.62Bondapack
1.33.82.72.25AlphaBond
Resolution BCD / HPBCDNot prescribed
Relative ret. of HPBCD
Prescribed: ~ 6
Relative ret. of BCD
Prescribed: ~ 4
Retention time of PRG
Prescribed: ~2.5 min
Phenyl stationary
phase